latest news releases from the newsroom
TASER International, Inc.
TASER International Names New Vice President of Information Technology
SCOTTSDALE, Ariz., July 16, 2008 (PRIME NEWSWIRE) -- TASER International, Inc. (Nasdaq:TASR), the market leader in advanced electronic control devices (ECDs), today announced that it has named Steve Berg as Vice President of Information Technology. Berg will provide strategy, organization, and process development to ensure a close alignment of departmental and organizational mission, strategies, and goals.
Cytomedix CEO Issues Shareholder Update
ROCKVILLE, Md., July 16, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) announced today that Chief Executive Officer Martin Rosendale issued the following letter to shareholders providing a general corporate update:
Chelsea Therapeutics Reports Progress in Phase II Trial of CH-1504 in Rheumatoid Arthritis
CHARLOTTE, N.C., July 16, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it has completed nearly 75% of the planned enrollment in its Phase II trial of CH-1504 in rheumatoid arthritis (RA) initiated in January 2008. CH-1504 is the lead drug candidate in Chelsea's portfolio of orally available, non-metabolized antifolate compounds engineered to provide the same potent efficacy as methotrexate (MTX) without the liver and kidney toxicities or tolerability related side effects associated with chronic therapy.